Gapping down
In reaction to earnings/guidance:
- SUM -10.5%, SIX -9.5%, EAT -5.1%, CHRW -5%, TWOU -4.9%, AKAM -4.5%, ANTM -4.1%, CHEF -3.7%, ZYXI -3.2%, YNDX -2.9%, FCAU -2.9%, HES -2.3%, UNM -2.2%, MSFT -2%, HA -1.8%, FTV -1.5%, TMHC -1.5%, DENN -1.4%, TW -1.3%, IART -1.2%, MXIM -1.1%, LSCC -0.8%, CME -0.8%
Other news:
- BBBY -8.8% (presenting at investor day)
- ELY -4% (to combine with Topgolf; also guides for Q3)
- CCL -3.8% (Princess Cruises extends pause in Australian ops thru May 2021)
- CZR -3.7% (CZR to sell Tropicana Evansville to GLPI and TRWH for $480 mln)
- EQT -2.5% (EQT to acquire Appalachia assets from CVX for $735 mln; also prices offering of 20 mln shares of common stock at $15.50 per share)
- CVX -2.2% (EQT to acquire Appalachia assets from CVX for $735 mln)
- EXAS -1.6% (issues statement regarding draft colorectal cancer screening guidelines)
Analyst comments:
- VNE -6.8% (downgraded to Underperform from Neutral at Credit Suisse)
- FANG -4% (downgraded to Equal Weight from Overweight at Barclays)
- FRO -3.5% (downgraded to Underperform from In-line at Evercore ISI)
- SAP -3.3% (removed from Goldman's Conviction Buy List)
- LVGO -2.4% (downgraded to Neutral from Overweight at Piper Sandler)
- FBK -2.3% (downgraded to Underweight from Neutral at JP Morgan)
- EXAS -1.6% (downgraded to Neutral from Buy at Citigroup)
- DTE -1.5% (downgraded to Market Perform from Outperform at BMO Capital Markets)